2020
Naltrexone + Bupropion Combination for the Treatment of Binge-eating Disorder with Obesity: A Randomized, Controlled Pilot Study
Grilo CM, Lydecker JA, Morgan PT, Gueorguieva R. Naltrexone + Bupropion Combination for the Treatment of Binge-eating Disorder with Obesity: A Randomized, Controlled Pilot Study. Clinical Therapeutics 2020, 43: 112-122.e1. PMID: 33218742, PMCID: PMC7902424, DOI: 10.1016/j.clinthera.2020.10.010.Peer-Reviewed Original ResearchConceptsBinge-eating disorderEating-disorder psychopathologyPilot RCTTreatment of BEDOutcome time pointDouble-blind treatmentPercentage of patientsControlled Pilot StudyDiscontinuation of medicationTreatment of bingeEvidence-based treatmentsBinge-eating frequencyBupropion combinationAdult patientsAdverse eventsComorbid obesitySecondary outcomesPrimary outcomeAcute effectsFunctional impairmentPlaceboLong-term effectsPatientsMost outcomesObesity
2016
We Use Dialysate Potassium Levels That Are Too Low in Hemodialysis
Tucker B, Moledina DG. We Use Dialysate Potassium Levels That Are Too Low in Hemodialysis. Seminars In Dialysis 2016, 29: 300-302. PMID: 27061895, DOI: 10.1111/sdi.12495.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsSudden cardiac deathCardiac deathDialysate potassium concentrationHigh ultrafiltration ratesShorter dialysis timeDialysis timeHigh riskPredialysis serum potassium concentrationPotassium concentrationSudden cardiac death accountsUltrafiltration rateCalcium concentrationDialysate potassium levelsLow potassium dialysateDiscontinuation of medicationTreatment of constipationSerum potassium concentrationCertain modifiable factorsLow potassiumPredialysis hyperkalemiaCardiovascular eventsHemodialysis patientsRetrospective studyModifiable factorsRisk factorsA Delphi process to address medication appropriateness for older persons with multiple chronic conditions
Fried TR, Niehoff K, Tjia J, Redeker N, Goldstein MK. A Delphi process to address medication appropriateness for older persons with multiple chronic conditions. BMC Geriatrics 2016, 16: 67. PMID: 26979576, PMCID: PMC4791884, DOI: 10.1186/s12877-016-0240-3.Peer-Reviewed Original ResearchConceptsMultiple medical conditionsMedication regimensOlder personsCaregiver reportsDelphi processAdverse medication effectsBlood pressure controlDiscontinuation of medicationMultiple chronic conditionsWeb-based anonymous surveyInappropriate regimensMedication appropriatenessMedication complexityOlder patientsDiabetes mellitusBlood sugarPatient goalsChronic conditionsMedication effectsGeneral internistsMedical conditionsMedicationsRegimensFamily practitionersCognitive impairment
2014
Treatment of binge eating disorder in racially and ethnically diverse obese patients in primary care: Randomized placebo-controlled clinical trial of self-help and medication
Grilo CM, Masheb RM, White MA, Gueorguieva R, Barnes RD, Walsh BT, McKenzie KC, Genao I, Garcia R. Treatment of binge eating disorder in racially and ethnically diverse obese patients in primary care: Randomized placebo-controlled clinical trial of self-help and medication. Behaviour Research And Therapy 2014, 58: 1-9. PMID: 24857821, PMCID: PMC4074556, DOI: 10.1016/j.brat.2014.04.002.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAnti-Obesity AgentsBinge-Eating DisorderBlack or African AmericanBody WeightCognitive Behavioral TherapyCombined Modality TherapyCyclobutanesDouble-Blind MethodFemaleHispanic or LatinoHumansMaleMiddle AgedObesityPrimary Health CareSelf CareTime FactorsTreatment OutcomeWhite PeopleYoung AdultConceptsSelf-help cognitive behavioral therapyDiverse obese patientsAnti-obesity medicationsObese patientsModerate clinical outcomePercent weight lossTime interaction effectsWeight lossClinical outcomesPrimary careRandomized placebo-controlled clinical trialSecond placebo-controlled trialPlacebo-controlled clinical trialAcute weight lossPlacebo-controlled trialDouble-blind fashionDiscontinuation of medicationPrimary care settingWeight loss maintenanceSpecialist treatment centresTreatment of bingeDiverse patient groupsSelf-help CBTBinge-eating frequencyDemographic factors
1998
The Assessment and Treatment of Binge Eating Disorder.
GRILO C. The Assessment and Treatment of Binge Eating Disorder. Journal Of Psychiatric Practice 1998, 4: 191. DOI: 10.1097/00131746-199807000-00002.Peer-Reviewed Original ResearchBehavioral weight control treatmentSignificant acute reductionDiscontinuation of medicationWeight control treatmentTreatment of bingeBehavioral weight controlPreliminary dataWeight control practicesBinge Eating DisorderAcute reductionPsychiatric morbidityRecurrent episodesNew diagnosisInterpersonal psychotherapyWeight controlBulimia nervosaDSM-IVInterpersonal therapyBingeDisorder categoriesWeight lossResearch criteriaEating DisordersTreatmentMultimodal assessmentCompliance With Medication Regimens for Mental and Physical Disorders
Cramer J, Rosenheck R. Compliance With Medication Regimens for Mental and Physical Disorders. Psychiatric Services 1998, 49: 196-201. PMID: 9575004, DOI: 10.1176/ps.49.2.196.Peer-Reviewed Original ResearchConceptsMedication complianceCompliance rateMicroelectronic monitoringMedication regimensPhysical disordersPsychiatric treatmentMedication compliance ratesDiscontinuation of medicationMean compliance rateAntidepressant medicationPill countAntipsychotic medicationNonpsychiatric disordersPatient compliancePsychiatric disordersPatientsPsychiatric patientsClinician judgmentMedicationsDisordersRegimensLower ratesTreatmentReportPercent
1986
Comparison of diflunisal and naproxen for relief of anterior knee pain.
Fulkerson J, Folcik M. Comparison of diflunisal and naproxen for relief of anterior knee pain. Clinical Therapeutics 1986, 9 Suppl C: 59-61. PMID: 3548986.Peer-Reviewed Original ResearchConceptsAnterior knee painKnee painNonsteroidal anti-inflammatory drugsComparison of diflunisalDiscontinuation of medicationAnti-inflammatory drugsEleven patientsAdverse reactionsModerate severitySignificant reliefPainSignificant differencesPatientsDiflunisalNaproxenReliefDiscontinuationMedicationsSeverity
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply